Prot# H3E-US-X065 / NU 05H8: Phase I/II Trial of Gemcitabine/Pemetrexed Combination in Patients with Advanced Cutaneous T-Cell Lymphoma

Project: Research project

Project Details

StatusFinished
Effective start/end date6/7/069/30/13

Funding

  • Eli Lilly and Company (H3E-US-X065 / NU 05H8)